Remission of severe myasthenia gravis after autologous stem cell transplantation is a research paper published in Annals of Clinical and Translational Neurology (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Rare Diseases Clinical Research Network
Grant: U54‐NS115054
NIAID NIH HHS
Grant: R01 AI114780
NINDS NIH HHS
Grant: U54 NS115054
NIAID NIH HHS
Grant: R56 AI114780
NCATS NIH HHS
Grant: UL1 TR001863
NIAID NIH HHS
Grant: R21 AI164590
National Institutes of Health
Grant: 1R21AI164590-01
Molecular determinants driving diverse mechanisms of antibody-mediated pathology
National Institutes of Health
Grant: 5U54NS115054-03
Rare Disease Network for Myasthenia Gravis
National Institutes of Health
Grant: 5R01AI114780-04
Mechanisms of autoantibody production in myasthenia gravis
Myasthenia Gravis Foundation of America
FWCI
1.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals